Pharma-grade synthetic camphor is extensively used in various topical analgesic products such as ointments, oils, gels, and chest-rubs. These pharma-grade synthetic camphor for topical pain management products are witnessing significant demand owing to consumer preference for self-medication, undergird by enhanced and easy accessibility of OTC products. According to the report, pharma-grade synthetic camphor is projected to account for more than 50% volume share in 2019 in the synthetic camphor market.

Pharma-grade synthetic camphor sales are also significantly driven by growing demand for private-labelled camphorated medical products. For example, private labelled analgesic products have gained increased popularity in the US, as they are devoid of FDA approval, and witness strong promotion from retailer businesses.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-8704

A key factor restricting adoption is regulations on the use of synthetic camphor in pharmaceutical products, such as the US FDA’s classification of certain camphorated oil products would require patients to hold doctor’s prescription for consumption. Moreover, rising costs of raw materials such as turpentine oil is emerging as a key concern for manufacturers producing pharma-grade synthetic camphor.

Gains Remain Strong from Synthetic Camphor Sales in Plasticizer Production

Synthetic camphor continues to witness robust adoption in plasticizer production, which prevails as a critical component for paint and coating formulations. Additionally, demand for plasticizers in PVC and cellulose fiber production, has significantly underpinned sales of synthetic camphor. The study estimates sales of synthetic camphor in plasticizer production to surpass 13 thousand tons in 2019.

Rise in the construction sector, along with increasing demand for renovation and maintenance of existing structures, continues to drive demand for plasticizers in flooring and wall covering applications. Additionally, remarkable demand for plasticizers in flexible Polyvinyl Chloride (PVC) manufacturing, and to soften plastics used in wall covering and flooring, will remain a key sales determinant of synthetic camphor.

East Asia to Hold Pole Position in Synthetic Camphor Market

According to the FMI report, East Asia is likely to remain lucrative in the synthetic camphor market. In East Asia, China is expected to account for the highest sales of synthetic camphor, surpassing 12 thousand tons in 2019. Owing to the presence of a large number of pharma-grade synthetic camphor manufacturers in China, the country is witnessing the growing demand for synthetic camphor.

Growing overseas demand for synthetic camphor and significant growth in Chinese gum turpentine industry are the key factors influencing the market growth in the country. Additionally, with the development of Chinese gum turpentine derivatives such as synthetic camphor and synthetic borneol, overseas companies are eyeing use of these derivatives over gum turpentine.

Majority of the pharma-grade synthetic camphor manufacturers are concentrated in China and India, exporting their products to Europe and the US. Due to the availability of raw materials and synthetic camphor on a large scale in China and India, global manufacturers of camphor and other related chemical are focusing on expanding their businesses in East Asia.

Request Report Methodology: https://www.futuremarketinsights.com/askus/rep-gb-8704

Synthetic camphor Market: Segmentation

Grade

• Technical Grade Synthetic Camphor
• Pharma Grade Synthetic Camphor

Application

• Pharmaceuticals
• Personal Care
• Plasticizer
• Flavour & Fragrance
• Others

Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-8704

The FMI report also tracks the synthetic camphor market for the forecast period 2018 to 2028. According to the report, volume sales of synthetic camphor is likely to register 3.0% CAGR through 2028.

For more insights contact FMI analysts at press@futuremarketinsights.com